Moolec Science (MLEC) Total Current Liabilities (2022 - 2025)
Moolec Science (MLEC) reported Total Current Liabilities of $61.9 million for Q4 2025, up 858.22% on a YoY basis from $6.5 million in Q4 2024, and down 73.78% sequentially from $236.1 million in Q2 2025.
Moolec Science (MLEC) Total Current Liabilities (2022 - 2025) Analysis & Trends
Moolec Science (MLEC) has 4 years of Total Current Liabilities data on file, last reported at $61.9 million in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities rose 858.22% year-over-year to $61.9 million; the trailing twelve-month figure through Dec 2025 stood at $61.9 million (up 858.22% YoY), and the FY2025 full-year result was $236.1 million, down 44.77% from the prior year.
- Total Current Liabilities fell to $61.9 million in Q4 2025, from $236.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $427.4 million in Q2 2024 to a low of $2.9 million in Q1 2023.
- A 4-year average of $66.7 million and a median of $9.8 million in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities surged 2829.09% in 2024 and slumped 44.77% in 2025, its largest moves.
- Tracing MLEC's Total Current Liabilities over 4 years: stood at $11.3 million in 2022, then decreased by 26.57% to $8.3 million in 2023, then decreased by 22.02% to $6.5 million in 2024, then jumped by 858.22% to $61.9 million in 2025.
- Business Quant data shows MLEC's Total Current Liabilities at $61.9 million in Q4 2025, $236.1 million in Q2 2025, and $6.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | 66.94 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 13.42 Mn |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | 1.81 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.88 Mn |
| Jun 30, 2025 | 236.05 Mn |
| Dec 31, 2024 | 6.46 Mn |
| Sep 30, 2024 | 7.36 Mn |
| Jun 30, 2024 | 427.40 Mn |
| Mar 31, 2024 | 7.82 Mn |
| Dec 31, 2023 | 8.28 Mn |
| Sep 30, 2023 | 12.51 Mn |
| Jun 30, 2023 | 14.59 Mn |
| Mar 31, 2023 | 2.92 Mn |
| Dec 31, 2022 | 11.28 Mn |
| Jun 30, 2022 | 4.09 Mn |